Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Nov;61 Suppl 2(Suppl 2):ii78-81.
doi: 10.1136/ard.61.suppl_2.ii78.

Type II collagen degradation and its regulation in articular cartilage in osteoarthritis

A R Poole  1 , M Kobayashi, T Yasuda, S Laverty, F Mwale, T Kojima, T Sakai, C Wahl, S El-Maadawy, G Webb, E Tchetina, W Wu
Affiliations
Review

Type II collagen degradation and its regulation in articular cartilage in osteoarthritis

A R Poole et al. Ann Rheum Dis. 2002 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagrammatic representation of some of the elements of cartilage structure and matrix turnover. Type II collagen fibrils form an endoskeleton and associated with them in interfibrillar sites resides the proteoglycan aggrecan aggregated with hyaluronic acid. In physiology there is active pericellular turnover of extracellular matrix involving proteolysis mediated by matrix metalloproteinases (MMPs). In OA there is increased damage to resident matrix molecules more remote from chondrocytes with up regulation of synthesis of collagen and proteoglycan. These new molecules are also subject to degradation. Degradation products are released to body fluids where they can be detected. Increased proteolysis involves up regulation of interleukin (IL)1 and tumour necrosis factor ß (TNFß) expression by chondrocytes, nitric oxide (NO) production, and receptor activation by matrix degradation products, which is IL1 and TNFα dependent. Reproduced with permission from references 35 and 36.
See this image and copyright information in PMC

References

    1. Arthritis Rheum. 1999 Nov;42(11):2381-9 - PubMed
    1. J Exp Med. 1999 Aug 16;190(4):535-42 - PubMed
    1. Arthritis Rheum. 2000 Sep;43(9):1916-26 - PubMed
    1. Arthritis Rheum. 2000 Sep;43(9):2121-31 - PubMed
    1. J Biol Chem. 2000 Dec 22;275(51):40307-15 - PubMed

Publication types

MeSH terms

Substances